Differences in cell kinetic changes among renal cancer cell lines treated with interferon-alpha
Citation
Y. Kasuya et al., Differences in cell kinetic changes among renal cancer cell lines treated with interferon-alpha, INT J UROL, 8(8), 2001, pp. 449-454
Categorie Soggetti
Urology & Nephrology
Journal title
INTERNATIONAL JOURNAL OF UROLOGY
SICI code
0919-8172(200108)8:8<449:DICKCA>2.0.ZU;2-7
Abstract
Background: Interferon (IFN)-alpha shows certain clinical effects on the tr
eatment of renal cell carcinoma. The purpose of the present study was to in
vestigate its direct effects and to compare the responses among different h
uman renal cancer cell lines.
Methods: Three cell lines, ACHN, RCC10RGB and OS-RC-2, were incubated with
IFN-alpha and evaluated using MTT assay for cell proliferation and two-colo
r flow cytometry for cell-cycle-specific cyclin expressions coupled with DN
A ploidy analysis.
Results: Interferon-alpha inhibited cell proliferation and caused cell accu
mulation at S and G2/M phases. However, IFN-alpha induced no significant ch
ange in cyclins D1, E, A or B1 expression. Interestingly, cell kinetic chan
ges caused by IFN-alpha were different among cell lines. Cell proliferation
was suppressed most in ACHN, then RCC10RGB and least in OS-RC-2. Comparing
DNA histograms, ACHN showed distinct increase of G2/M cells associated wit
h elevation of late S cells. RCC10RGB showed a predominant increase of whol
e S cells accompanied with a slight increase of G2/M. OS-RC-2 showed a mode
st increase of S cells with a little change of G2/M cells. Chronological ob
servation revealed that S-phase increase and proliferative inhibition appea
red on day 1 and day 3, respectively, in ACHN and RCC10RGB, and on day 5 in
OS-RC-2.
Conclusions: Interferon-a induced substantial cell kinetic interference dir
ectly in the tested human renal carcinoma cell lines. The degree of change
was different according to the nature of the cell line. It may partly indic
ate the variety of the efficacy of IFN-alpha treatment against renal cancer
s.